David Karis

Creating Novel Activated Factor XI Inhibitors through Fragment Based Lead Generation and Structure Aided Drug Design

O. Fjellström, I. Nilsson, T. Olsson, 2015, PloS one.

Direct AMP-activated protein kinase activators: a review of evidence from the patent literature

F. Giordanetto, D. Karis, David Karis, 2012, Expert opinion on therapeutic patents.

Structure-activity relationships for the linker in a series of pyridinyl-alkynes that are antagonists of the metabotropic glutamate receptor 5 (mGluR5).

A. Wallberg, David Wensbo, P. Bach, 2006, Bioorganic & medicinal chemistry letters.